Search

Your search keyword '"Yannoukakos, Drakoulis"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Yannoukakos, Drakoulis" Remove constraint Author: "Yannoukakos, Drakoulis" Topic breast neoplasms Remove constraint Topic: breast neoplasms
126 results on '"Yannoukakos, Drakoulis"'

Search Results

1. ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

2. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

3. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.

4. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

6. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.

7. When cascade testing for familial variant seems inadequate to provide clinically actionable information for blood relatives.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

10. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.

11. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

12. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

13. Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.

14. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene.

15. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

16. PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.

17. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

18. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

19. Shared heritability and functional enrichment across six solid cancers.

20. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

21. Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece.

22. Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.

23. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

24. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

25. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.

26. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

27. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

28. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

29. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

30. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.

31. RAD51B in Familial Breast Cancer.

32. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

33. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.

34. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

35. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.

36. Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece.

37. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

38. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

39. Prediction of breast cancer risk based on profiling with common genetic variants.

40. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

41. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

42. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

43. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

44. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

45. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

46. MicroRNA related polymorphisms and breast cancer risk.

47. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

48. Breast-cancer risk in families with mutations in PALB2.

49. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

50. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

Catalog

Books, media, physical & digital resources